• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于列线图模型预测 2 型糖尿病患者的糖尿病视网膜病变风险。

Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model.

机构信息

Department of Endocrinology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Department of Dermatology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

出版信息

Front Endocrinol (Lausanne). 2022 Nov 16;13:993423. doi: 10.3389/fendo.2022.993423. eCollection 2022.

DOI:10.3389/fendo.2022.993423
PMID:36465620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9710381/
Abstract

BACKGROUND

This study aims to develop a diabetic retinopathy (DR) hazard nomogram for a Chinese population of patients with type 2 diabetes mellitus (T2DM).

METHODS

We constructed a nomogram model by including data from 213 patients with T2DM between January 2019 and May 2021 in the Affiliated Hospital of Zunyi Medical University. We used basic statistics and biochemical indicator tests to assess the risk of DR in patients with T2DM. The patient data were used to evaluate the DR risk using R software and a least absolute shrinkage and selection operator (LASSO) predictive model. Using multivariable Cox regression, we examined the risk factors of DR to reduce the LASSO penalty. The validation model, decision curve analysis, and C-index were tested on the calibration plot. The bootstrapping methodology was used to internally validate the accuracy of the nomogram.

RESULTS

The LASSO algorithm identified the following eight predictive variables from the 16 independent variables: disease duration, body mass index (BMI), fasting blood glucose (FPG), glycated hemoglobin (HbA1c), homeostatic model assessment-insulin resistance (HOMA-IR), triglyceride (TG), total cholesterol (TC), and vitamin D (VitD)-T3. The C-index was 0.848 (95% CI: 0.798-0.898), indicating the accuracy of the model. In the interval validation, high scores (0.816) are possible from an analysis of a DR nomogram's decision curve to predict DR.

CONCLUSION

We developed a non-parametric technique to predict the risk of DR based on disease duration, BMI, FPG, HbA1c, HOMA-IR, TG, TC, and VitD.

摘要

背景

本研究旨在为中国 2 型糖尿病(T2DM)患者开发一种糖尿病视网膜病变(DR)危险诺模图。

方法

我们通过纳入遵义医科大学附属医院 2019 年 1 月至 2021 年 5 月的 213 例 T2DM 患者的数据,构建了一个诺模图模型。我们使用基本统计和生化指标测试来评估 T2DM 患者发生 DR 的风险。使用 R 软件和最小绝对收缩和选择算子(LASSO)预测模型对患者数据进行 DR 风险评估。使用多变量 Cox 回归检查 DR 的风险因素,以减少 LASSO 惩罚。使用校准图测试验证模型、决策曲线分析和 C 指数。使用 bootstrap 方法对列线图的准确性进行内部验证。

结果

LASSO 算法从 16 个独立变量中确定了以下八个预测变量:疾病持续时间、体重指数(BMI)、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、稳态模型评估-胰岛素抵抗(HOMA-IR)、甘油三酯(TG)、总胆固醇(TC)和维生素 D(VitD)-T3。C 指数为 0.848(95%CI:0.798-0.898),表明模型的准确性。在间隔验证中,对 DR 列线图决策曲线的分析可能会得出高得分(0.816),以预测 DR。

结论

我们开发了一种基于疾病持续时间、BMI、FPG、HbA1c、HOMA-IR、TG、TC 和 VitD 的非参数技术来预测 DR 的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/a56344d2adac/fendo-13-993423-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/d93c949eff17/fendo-13-993423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/2ccfa699f245/fendo-13-993423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/ec42b7db5802/fendo-13-993423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/fc14f71e956a/fendo-13-993423-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/7f73636ba688/fendo-13-993423-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/a56344d2adac/fendo-13-993423-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/d93c949eff17/fendo-13-993423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/2ccfa699f245/fendo-13-993423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/ec42b7db5802/fendo-13-993423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/fc14f71e956a/fendo-13-993423-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/7f73636ba688/fendo-13-993423-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20a1/9710381/a56344d2adac/fendo-13-993423-g006.jpg

相似文献

1
Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model.基于列线图模型预测 2 型糖尿病患者的糖尿病视网膜病变风险。
Front Endocrinol (Lausanne). 2022 Nov 16;13:993423. doi: 10.3389/fendo.2022.993423. eCollection 2022.
2
Nomogram-Based Prediction of the Risk of Diabetic Retinopathy: A Retrospective Study.基于列线图的糖尿病视网膜病变风险预测:一项回顾性研究。
J Diabetes Res. 2020 Jun 7;2020:7261047. doi: 10.1155/2020/7261047. eCollection 2020.
3
Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy.基于视网膜几何形状的糖尿病视网膜病变早期评估预测风险模型的建立与验证。
Front Endocrinol (Lausanne). 2022 Nov 21;13:1033611. doi: 10.3389/fendo.2022.1033611. eCollection 2022.
4
Development and external validation of a predictive model for type 2 diabetic retinopathy.开发并验证用于预测 2 型糖尿病视网膜病变的模型。
Sci Rep. 2024 Jul 20;14(1):16741. doi: 10.1038/s41598-024-67533-5.
5
Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: A retrospective study.预测 2 型糖尿病患者糖尿病视网膜病变的列线图:一项回顾性研究。
J Diabetes Complications. 2022 Nov;36(11):108313. doi: 10.1016/j.jdiacomp.2022.108313. Epub 2022 Sep 21.
6
Dynamic nomogram prediction model for diabetic retinopathy in patients with type 2 diabetes mellitus.2 型糖尿病患者糖尿病视网膜病变的动态列线图预测模型。
BMC Ophthalmol. 2023 Apr 28;23(1):186. doi: 10.1186/s12886-023-02925-1.
7
Prediction of diabetic retinopathy among type 2 diabetic patients in University of Gondar Comprehensive Specialized Hospital, 2006-2021: A prognostic model.2006-2021 年,贡德尔大学综合专科医院 2 型糖尿病患者糖尿病视网膜病变的预测:预后模型。
Int J Med Inform. 2024 Oct;190:105536. doi: 10.1016/j.ijmedinf.2024.105536. Epub 2024 Jul 5.
8
Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study.基于问卷调查和生化指标的2型糖尿病患者糖尿病肾病或糖尿病视网膜病变风险列线图:一项横断面研究
Diabetes Metab Syndr Obes. 2020 Apr 20;13:1215-1229. doi: 10.2147/DMSO.S244061. eCollection 2020.
9
Development and validation of a model that predicts the risk of diabetic retinopathy in type 2 diabetes mellitus patients.预测2型糖尿病患者糖尿病视网膜病变风险模型的开发与验证
Acta Diabetol. 2023 Jan;60(1):43-51. doi: 10.1007/s00592-022-01973-1. Epub 2022 Sep 26.
10
Development and validation of a diabetic retinopathy risk prediction model for middle-aged patients with type 2 diabetes mellitus.开发和验证 2 型糖尿病中年患者糖尿病视网膜病变风险预测模型。
Front Endocrinol (Lausanne). 2023 Mar 15;14:1132036. doi: 10.3389/fendo.2023.1132036. eCollection 2023.

引用本文的文献

1
Development and Validation of a Nomogram-Based Risk Prediction Model for Diabetic Retinopathy in Elderly Adults with Type 2 Diabetes Mellitus.2型糖尿病老年患者糖尿病视网膜病变基于列线图的风险预测模型的开发与验证
Diabetes Metab Syndr Obes. 2025 Jul 25;18:2509-2523. doi: 10.2147/DMSO.S530424. eCollection 2025.
2
Development and validation of prediction models for diabetic retinopathy in type 2 diabetes patients.2型糖尿病患者糖尿病视网膜病变预测模型的开发与验证
PLoS One. 2025 Jul 10;20(7):e0325814. doi: 10.1371/journal.pone.0325814. eCollection 2025.
3
Study on the prevalence of diabetic retinopathy in Pudong New Area and the predictive value of estimated glucose disposal rate: a cross-sectional study.

本文引用的文献

1
Nomogram for Prediction of Diabetic Retinopathy Among Type 2 Diabetes Population in Xinjiang, China.中国新疆2型糖尿病人群糖尿病视网膜病变预测列线图
Diabetes Metab Syndr Obes. 2022 Apr 7;15:1077-1089. doi: 10.2147/DMSO.S354611. eCollection 2022.
2
Comparison of VEGF level in tears post phacoemulsification between non-proliferative diabetic retinopathy and non-diabetic patients.非增殖性糖尿病视网膜病变患者与非糖尿病患者白内障超声乳化术后泪液中血管内皮生长因子水平的比较。
J Diabetes Metab Disord. 2021 Aug 20;20(2):2073-2079. doi: 10.1007/s40200-021-00875-3. eCollection 2021 Dec.
3
Development and Evaluation of a New Predictive Nomogram for Predicting Risk of Herpes Zoster Infection in a Chinese Population with Type 2 Diabetes Mellitus.
浦东新区糖尿病视网膜病变患病率及估计葡萄糖处置率的预测价值研究:一项横断面研究。
Front Endocrinol (Lausanne). 2025 Jun 25;16:1571488. doi: 10.3389/fendo.2025.1571488. eCollection 2025.
4
Universal nomogram for predicting referable diabetic retinopathy: a validated model for community and ophthalmic outpatient populations using easily accessible indicators.预测可转诊糖尿病视网膜病变的通用列线图:一种使用易于获取的指标针对社区和眼科门诊人群验证的模型
Front Endocrinol (Lausanne). 2025 Jun 12;16:1557166. doi: 10.3389/fendo.2025.1557166. eCollection 2025.
5
Polyunsaturated fatty acids and diabetic microvascular complications: a Mendelian randomization study.多不饱和脂肪酸与糖尿病微血管并发症:一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Aug 7;15:1406382. doi: 10.3389/fendo.2024.1406382. eCollection 2024.
6
Mendelian randomization study and mediation analysis about the relation of inflammatory bowel disease and diabetic retinopathy: the further exploration of gut-retina axis.基于孟德尔随机化研究和中介分析探讨炎症性肠病与糖尿病视网膜病变的关系:肠道-视网膜轴的进一步探索。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1382777. doi: 10.3389/fendo.2024.1382777. eCollection 2024.
7
Effect of High-Sucrose Diet on the Occurrence and Progression of Diabetic Retinopathy and Dietary Modification Strategies.高糖饮食对糖尿病视网膜病变的发生和进展的影响及饮食调整策略。
Nutrients. 2024 May 5;16(9):1393. doi: 10.3390/nu16091393.
8
Construction and clinical validation of a nomogram-based predictive model for diabetic retinopathy in type 2 diabetes.2型糖尿病视网膜病变基于列线图预测模型的构建与临床验证
Am J Transl Res. 2023 Oct 15;15(10):6083-6094. eCollection 2023.
9
Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.2型糖尿病与结直肠癌之间共享基因特征及生物学机制的鉴定。
Front Genet. 2023 Oct 9;14:1202849. doi: 10.3389/fgene.2023.1202849. eCollection 2023.
10
Correlation between glycated hemoglobin A1c, urinary microalbumin, urinary creatinine, β2 microglobulin, retinol binding protein and diabetic retinopathy.糖化血红蛋白A1c、尿微量白蛋白、尿肌酐、β2微球蛋白、视黄醇结合蛋白与糖尿病视网膜病变之间的相关性。
World J Diabetes. 2023 Jul 15;14(7):1103-1111. doi: 10.4239/wjd.v14.i7.1103.
一种用于预测中国 2 型糖尿病患者带状疱疹感染风险的新型预测列线图的开发与评估
Risk Manag Healthc Policy. 2021 Nov 27;14:4789-4797. doi: 10.2147/RMHP.S310938. eCollection 2021.
4
Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes.长期糖化血红蛋白变异性与 2 型糖尿病患者糖尿病视网膜病变的发生和进展。
Sci Rep. 2021 Feb 26;11(1):4731. doi: 10.1038/s41598-021-84150-8.
5
The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy.糖化血红蛋白(HbA1c)与其他生物标志物和糖尿病视网膜病变的患病率及严重程度之间的关联。
Cureus. 2021 Jan 6;13(1):e12520. doi: 10.7759/cureus.12520.
6
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects.维生素 D 在糖尿病视网膜病变中的作用:病理生理和临床方面。
Rev Endocr Metab Disord. 2021 Dec;22(4):715-727. doi: 10.1007/s11154-020-09575-4.
7
Predicting Risk of Insulin Resistance in a Chinese Population with Polycystic Ovary Syndrome: Designing and Testing a New Predictive Nomogram.多囊卵巢综合征中国人群胰岛素抵抗风险预测:新型预测列线图的设计与验证。
Biomed Res Int. 2020 Jun 13;2020:8031497. doi: 10.1155/2020/8031497. eCollection 2020.
8
Nomogram-Based Prediction of the Risk of Diabetic Retinopathy: A Retrospective Study.基于列线图的糖尿病视网膜病变风险预测:一项回顾性研究。
J Diabetes Res. 2020 Jun 7;2020:7261047. doi: 10.1155/2020/7261047. eCollection 2020.
9
Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study.基于问卷调查和生化指标的2型糖尿病患者糖尿病肾病或糖尿病视网膜病变风险列线图:一项横断面研究
Diabetes Metab Syndr Obes. 2020 Apr 20;13:1215-1229. doi: 10.2147/DMSO.S244061. eCollection 2020.
10
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.中国 2018 年美国糖尿病协会诊断标准下的中国大陆糖尿病患病率:全国横断面研究。
BMJ. 2020 Apr 28;369:m997. doi: 10.1136/bmj.m997.